ARTICLE | Company News
Sangamo receives option payment
March 10, 2000 8:00 AM UTC
Sangamo received a $7.5 million option payment from Baxter (BAX) under the companies' January agreement to develop therapeutics for ischemic cardiovascular and peripheral vascular diseases. BAX exerci...